Cancer Killing Clue Could Lead to More Powerful Immunotherapies
News Feb 13, 2018 | Original story from the Walter and Eliza Hall Institute
A new study led by Dr Misty Jenkins and colleagues at Peter Mac could lead to safer immunotherapies for solid cancers. Credit: Walter and Eliza Hall Institute
New research could help to safely adapt a new immunotherapy - currently only effective in blood cancers - for the treatment of solid cancers, such as notoriously hard-to-treat brain tumours.
The study, led by Dr Misty Jenkins from the Walter and Eliza Hall Institute of Medical Research, explains the crucial mechanisms by which CAR-T cell therapy is able to rapidly target and kill cancer cells, and why it may cause serious side effects.
CAR-T cell therapy is an innovative form of immunotherapy that uses synthetically engineered T cells to redirect the patient's own immune system to fight their cancer. Approved by the US Food and Drug Administration (FDA) in 2017, it has been successfully used to treat blood cancers such as childhood leukaemia and some lymphomas.
Unfortunately, CAR-T cell therapy has had mixed results in solid cancers, often causing significant side effects such as 'cytokine storms' - a potentially fatal inflammatory response that can lead to organ failure in some patients.
Dr Jenkins led the study, working with collaborators Mr Alex Davenport, Associate Professor Phillip Darcy and Associate Professor Paul Neeson from the Peter Mac. It was published today in the journal Proceedings of the National Academy of Sciences.
Dr Jenkins said the new research revealed for the first time how CAR-T cells interacted with cancer cells.
"We found that CAR-T cell receptors have the ability to rapidly identify and bind to tumour cells that would otherwise remain undetected in the immune system, and promptly kill them.
"We have previously shown a correlation between cytokine production and the length of time the immune cells were latched onto the cancer cells. The longer the cells were in contact, the more cytokines were produced, causing ever increasing degrees of damage from inflammation," she said.
Dr Jenkins said a deep understanding of the biological factors contributing to the success and side effects of CAR-T cells would help to inform a better design and safer delivery methods for the personalised therapy.
"Our research is teaching us how to make CAR-T cells even more efficient, and without the toxic side effects, so that we can safely extend the therapy to cover a broader range of cancers," she said.
Dr Jenkins said her research focused on how CAR-T cell therapy could successfully be used to treat brain cancer. Brain cancer has some of the poorest survival rates of any cancer in the world and desperately requires new treatment approaches.
"The brain is an incredibly delicate and challenging environment to work within," Dr Jenkins said.
"Brain tumours are often resistant to traditional treatments, such as chemotherapy; and surgically removing tumours can come with a lot of collateral damage.
"Finding an optimum design for CAR-T cell therapy where we can kill tumour cells with limited invasion, inflammation and side effects could significantly improve the treatment of brain cancer.
"Answering fundamental biological questions about how immune cells and cancer cells function and interact, as we have done in this study, is invaluable in the quest to find formidable treatments for fatal cancers," she said.
In 2017 Dr Jenkins received a Carrie's Beanies 4 Brain Cancer Foundation grant and a Financial Market's Foundation for Children Grant to continue her work to develop CAR-T cell therapies and other forms of immunotherapy for treating children with brain cancer.
This article has been republished from materials provided by Walter and Eliza Hall Institute. Note: material may have been edited for length and content. For further information, please contact the cited source.
Electrical Implant Reduces "Invisible" Symptoms of Man's Spinal Cord Injury- StudyNews
An electrical implant could improve daily activities for people with spinal cord injuries.READ MORE
Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”News
Many companies involved in cancer drug research and development need to re-think their use of safety data in helping to bring new drugs to cancer patients.
Dr Richard Knight of ApconiX will tell this month’s conference, that greater focus on pre-clinical safety should be fundamental to the development of new cancer therapies.
Brainwaves Show How Exercising to Music Bends Your MindNews
Research has found that music rearranges the brain’s electrical frequency, causing a drop in focus but enhancing enjoyment 28% more than silence and 13% more than a podcast.READ MORE
Comments | 1 ADD COMMENT
Sorice Madina | Feb 15, 2018
I have had emphysema for about five years. I was on oxygen during the day but not at night. I could go about two hours without the oxygen, and then I need it. I had a converter in the house and oxygen tanks for when I go shopping, etc. I am 64 years old and in relatively good health. The doctor said it was caused by a combination of smoking, dust here in Vegas, and 30 years of smog in California. I believed I will always need the oxygen to breathe. I quit smoking 15 years ago. But the damage has been done. January 2017 my pulmonologist and I decided to go with natural treatment and was introduced to Green House Herbal Clinic natural organic Emphysema Herbal formula, i had a total decline of symptoms with this Emphysema Herbal formula treatment. Visit Green House Herbal Clinic official web-site ww w. greenhouseherbalclinic. com. The infections, shortness of breath, fatigue, dry cough and other symptoms has subsided. I am very pleased with this treatment. I breath very well now and exercise regularly, sometimes i totally forget i ever had Emphysema, I am thankful to nature, the medics failed. Share with friends!!
Like what you just read? You can find similar content on the communities below.Analysis & Separations Cancer Research Cell Science Drug Discovery Informatics Neuroscience Immunology & Microbiology
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE